• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

News

Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriers

18 de June de 2019
Cancer Gene Ther. 2020 May;27(5):383-388. doi: 10.1038/s41417-019-0110-1.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2019-06-18 10:00:002019-06-18 10:00:00Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriers

Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer

16 de June de 2019
Cancers (Basel). 2019 Jun 13;11(6):817. doi: 10.3390/cancers11060817.ABSTRACTUveal…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2019-06-16 10:00:002019-06-16 10:00:00Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer

New perspectives on screening and early detection of endometrial cancer

15 de June de 2019
Int J Cancer. 2019 Dec 15;145(12):3194-3206. doi: 10.1002/ijc.32514.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-06-15 10:00:002019-06-15 10:00:00New perspectives on screening and early detection of endometrial cancer

New perspectives on screening and early detection of endometrial cancer

15 de June de 2019
Int J Cancer. 2019 Dec 15;145(12):3194-3206. doi: 10.1002/ijc.32514.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2019-06-15 10:00:002019-06-15 10:00:00New perspectives on screening and early detection of endometrial cancer

Quantification of gold nanoparticle accumulation in tissue by two-photon luminescence microscopy

6 de June de 2019
Nanoscale. 2019 Jun 13;11(23):11331-11339. doi: 10.1039/c9nr01198f.ABSTRACTNanomedicine…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-06-06 10:00:002019-06-06 10:00:00Quantification of gold nanoparticle accumulation in tissue by two-photon luminescence microscopy

Assessment of Genetic Diversity of HTLV-1 ORF-I Sequences Collected from Patients with Different Clinical Profiles

4 de June de 2019
AIDS Res Hum Retroviruses. 2019 Sep;35(9):881-884. doi: 10.1089/AID.2019.0127.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-06-04 10:00:002019-06-04 10:00:00Assessment of Genetic Diversity of HTLV-1 ORF-I Sequences Collected from Patients with Different Clinical Profiles

Computational de-orphanization of the olive oil biophenol oleacein: Discovery of new metabolic and epigenetic targets

1 de June de 2019
Food Chem Toxicol. 2019 Sep;131:110529. doi: 10.1016/j.fct.2019.05.037.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-06-01 10:00:002019-06-01 10:00:00Computational de-orphanization of the olive oil biophenol oleacein: Discovery of new metabolic and epigenetic targets

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

12 de May de 2019
Aging (Albany NY). 2019 May 9;11(9):2874-2888. doi: 10.18632/aging.101960.ABSTRACTCertain…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-05-12 10:00:002019-05-12 10:00:00Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

Stratification of cancer and diabetes based on circulating levels of formate and glucose

4 de May de 2019
Cancer Metab. 2019 Apr 24;7:3. doi: 10.1186/s40170-019-0195-x.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-05-04 10:00:002019-05-04 10:00:00Stratification of cancer and diabetes based on circulating levels of formate and glucose

A multiscale model of epigenetic heterogeneity-driven cell fate decision-making

1 de May de 2019
PLoS Comput Biol. 2019 Apr 30;15(4):e1006592. doi: 10.1371/journal.pcbi.1006592.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-05-01 10:00:002019-05-01 10:00:00A multiscale model of epigenetic heterogeneity-driven cell fate decision-making

A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis

20 de April de 2019
Eur Respir J. 2019 Jun 27;53(6):1900329. doi: 10.1183/13993003.00329-2019.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-04-20 10:00:002019-04-20 10:00:00A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

16 de April de 2019
Front Oncol. 2019 Mar 28;9:193. doi: 10.3389/fonc.2019.00193.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-04-16 10:00:002019-04-16 10:00:00The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
Page 52 of 87«‹5051525354›»

Filter by categories

  • Alemany’s & Piulats’s lab (133)
  • Antolin's lab (36)
  • Aytes's Lab (25)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sin categoría (5)
  • Sureda's & Farre's Lab (312)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}